UroGen Pharma URGN Asset turnover
Asset turnover at other companies
Other financials
Where this comes from
Calculated from UroGen Pharma’s reported figures.
Based on trailing twelve months.
The official record: UroGen Pharma’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about UroGen Pharma's asset turnover.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is UroGen Pharma's asset turnover?
- UroGen Pharma (URGN) reported asset turnover of 0.6× in Q1 2026.
- How has UroGen Pharma's asset turnover changed year-over-year?
- UroGen Pharma's asset turnover increased by 36.7% year-over-year, from 0.4× to 0.6×.
- What is the long-term trend for UroGen Pharma's asset turnover?
- Over 5 years (2020 to 2025), UroGen Pharma's asset turnover has grown at a 44.1% compound annual growth rate (CAGR), from 0.1× to 0.5×.
- What does asset turnover mean?
- Trailing-twelve-month revenue divided by average total assets. Measures how many dollars of sales each dollar of assets generates — the efficiency leg of the DuPont decomposition of ROE.